InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (26 ops.)
Discover the full record of transactions filed by Treace John T., Chief Executive Officer. Insider active across 1 companies, notably Treace Medical Concepts, INC.. Aggregated, 30 disclosures have been logged. Total volume traded: €11.7m. The latest transaction was filed on 12 May 2026 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations30 total
US$79,65443,000 shares@ US$1.85240.046% mcap3.0% of flow
Common Stock
SEC:0001193125-26-224391·
Ideal exit: 6 Feb 2027 (T+270)
€79,65443,000 shares@ €1.85240.046% mcap1.5% of flow
Common Stock
SEC:0001193125-26-224391:0·
Ideal exit: 6 Feb 2027 (T+270)
€267,92220,809 shares@ €12.87530.16% mcap4.2% of flow
Common Stock
SEC:0001567619-22-013208:0·
€435,42630,313 shares@ €14.36430.25% mcap6.8% of flow
Common Stock
SEC:0001567619-22-011883:0·
0450,000 shares0
Common Stock
SEC:0001567619-22-006925:0·
033,875 shares0
Common Stock
SEC:0001567619-22-006730:0·
€613,18236,144 shares@ €16.9650.36% mcap21.4% of flow
Common Stock
SEC:0001567619-22-001384·
€613,18236,144 shares@ €16.9650.36% mcap9.5% of flow
Common Stock
SEC:0001567619-22-001384:0·
€23,2891,563 shares@ €14.90030.013% mcap0.8% of flow
Common Stock
SEC:0001567619-21-022714·
€296,38319,760 shares@ €14.99920.17% mcap11.3% of flow
Common Stock
SEC:0001567619-21-022717·
€23,2891,563 shares@ €14.90030.013% mcap0.4% of flow
Common Stock
SEC:0001567619-21-022714:0·
€296,38319,760 shares@ €14.99920.17% mcap5.7% of flow
Common Stock
SEC:0001567619-21-022717:0·
€337,27823,390 shares@ €14.41980.20% mcap11.8% of flow
Common Stock
SEC:0001567619-21-022541·
€601,86241,710 shares@ €14.42970.35% mcap11.5% of flow
Common Stock
SEC:0001567619-21-022542:0·
€601,86241,710 shares@ €14.42970.35% mcap22.9% of flow
Common Stock
SEC:0001567619-21-022542·
€337,27823,390 shares@ €14.41980.20% mcap5.2% of flow
Common Stock
SEC:0001567619-21-022541:0·
€219,31515,719 shares@ €13.95220.13% mcap7.7% of flow
Common Stock
SEC:0001567619-21-022459·
€219,31515,719 shares@ €13.95220.13% mcap3.4% of flow
Common Stock
SEC:0001567619-21-022459:0·
€312,28022,311 shares@ €13.99670.18% mcap6.0% of flow
Common Stock
SEC:0001567619-21-022460:0·
€312,28022,311 shares@ €13.99670.18% mcap11.9% of flow
Common Stock
SEC:0001567619-21-022460·
€1m74,526 shares@ €14.25840.62% mcap16.5% of flow
Common Stock
SEC:0001567619-21-022289:0·
€1m74,526 shares@ €14.25840.62% mcap37.1% of flow
Common Stock
SEC:0001567619-21-022289·
€851,53852,354 shares@ €16.2650.49% mcap32.5% of flow
Common Stock
SEC:0001567619-21-021184·
€851,53852,354 shares@ €16.2650.49% mcap16.2% of flow
Common Stock
SEC:0001567619-21-021184:0·
€260,25615,854 shares@ €16.41580.15% mcap4.0% of flow
Common Stock
SEC:0001567619-21-021185:0·
25 of 30 declarations
About Treace John T.
John T. Treace is the Chief Executive Officer of TREACE MEDICAL CONCEPTS, INC. He leads the company's strategic operations and ensures the implementation of growth objectives. His industry experience enables him to make informed decisions that promote the long-term success of TREACE.
